Thursday, 29 August 2019

Reuters Health Report: Private health firms plan 'conquest' of Eastern Europe

Reuters.com Newsletter

Private health firms plan 'conquest' of Eastern Europe

Csilla Balla became anxious after her doctor told her she would need surgery to remove a benign skin growth on her face, and she decided to go back to see her to discuss other options.

Global measles cases three times higher than last year: WHO

Every region in the world, except the Americas, is experiencing an increase in the number of cases of measles, a vaccine-preventable disease that can kill or disable children, the World Health Organization (WHO) said on Thursday.

AstraZeneca lupus drug shows promise after set-back last year

AstraZeneca Plc said on Thursday its experimental drug to treat moderate-to-severe lupus met the main goal in a late-stage study, an encouraging sign after it failed to meet its main target in the final stage of another trial last year.

Roche immunotherapy Tecentriq gains European approval for breast cancer

Roche's Tecentriq has won European approval for use against a tough-to-treat breast cancer, helping the Swiss drugmaker to widen use of an immunotherapy that has so far been eclipsed in revenue terms by more-established rival medicines.

U.S. to pay for thousands of doses of HIV drugs for Venezuelan migrants

The United States said on Wednesday it will provide thousands of doses of HIV medication to treat Venezuelans in Colombia as part of regional efforts to manage care for millions of migrants fleeing the crisis-hit nation.

U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight

A U.S. judge on Wednesday set aside a jury verdict that found Amgen Inc patents on its cholesterol drug Repatha were valid, handing a victory to Regeneron Pharmaceuticals Inc and Sanofi SA, which sells a rival drug.

Pinterest will direct vaccine searches to major health groups

Pinterest Inc users searching for vaccine-related information will be shown results from leading public health groups, in an effort to combat health misinformation on the site, the social media company said in a blog post on Wednesday.

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday.

Football concussions tied to middle-age erectile dysfunction

(Reuters Health) - Former professional U.S. football players with a history of concussions may be more likely to experience low testosterone and erectile dysfunction later in life, a recent study suggests.

More U.S. teens exposed to secondhand e-cigarette vapor

(Reuters Health) - Exposure to secondhand chemicals emitted from e-cigarettes is on the rise among middle- and high-school students, a new study suggests.

Hard to tell how common sesame allergy may be

(Reuters Health) - Roughly half of children and adults who say they're allergic to sesame don't have a history of convincing symptoms, a U.S. study suggests.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS